Contacts

Professor Mohamad Mohty (EBMT President) at the 58th Annual Meeting of the American Society of Hematology (ASH)
 
This video has been displayed with permission from the Video Journal of Hematological Oncology (http://www.vjhemonc.com/). 
(c) Magdalen Medical Publishing 2017

 

MolMed S.p.A. is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer.

Important stuff

News

Dec 3, 2016 - Dec 6, 2016
Last update: Nov 30, 2016
Nov 29, 2016
Last update: Nov 29, 2016
Products of excellence

GMP Solutions

MolMed GMP Solutions provides tailor-made services for your cell & gene therapy projects.

Last presentation

Nov 29, 2016
Company presentation - November 29, 2016

Financial reports

Annual financial report (English translation for convenience) 2015
Interim financial report - in Italian, English translation to come at 09/30/2016
Half-year financial report -English translation for convenience at 06/30/2016
Interim financial report (English translation for convenience) at 03/31/2016

MolMed S.p.A. Via Olgettina, 58 - 20132 Milano, Italy | Phone +39 0221277.1 - Fax +39 02 21277.325 | info@molmed.com - www.molmed.com
Share capital € 20,312,682.30 fully paid - Office of Milan Company Registry number 1506630 - Tax identification number 11887610159